Sandbox Reserved 433
From Proteopedia
(Difference between revisions)
| (77 intermediate revisions not shown.) | |||
| Line 2: | Line 2: | ||
{{Template:Sandbox Reserved Lynmarie Thompson}} | {{Template:Sandbox Reserved Lynmarie Thompson}} | ||
<!-- INSERT YOUR SCENES AND TEXT BELOW THIS LINE --> | <!-- INSERT YOUR SCENES AND TEXT BELOW THIS LINE --> | ||
| - | <Structure load=' | ||
| - | ==''' | + | =='''Estrogen receptor beta/p-hydroxybenzene sulfonamide complexes (2yly)<ref>PMID: 21885279 </ref>'''== |
| - | + | by Benjamin Homyak, Soo Lim Park, Marissa Burgess | |
| + | [[Student Projects for UMass Chemistry 423 Spring 2016]] | ||
| + | <StructureSection load='2yly' size='350' side='right' caption='p-hydroxybenzenesulphonamides ERb receptor (PDB entry [[2yly]])' scene=''> | ||
==Introduction== | ==Introduction== | ||
| - | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. | ||
| - | + | Estrogen receptors are proteins found on and inside of the cell. When activated by estrogen these receptors are important in sexual maturation and gestation. There are two types of estrogen receptors that exist which include nuclear estrogen receptors (ERα and ERβ), which are included in the nuclear receptor family of intracellular receptors, and membrane estrogen receptors. | |
| - | + | ||
| - | + | A series of p-hydroxybenzenesulphonamides ERβ receptor agonists discovered along with various compounds listed showed selectivity over the ERα receptor. Overall, they found that compound 11 showed better binding conformation determined by X-ray, and presents a better starting point for the journey to find a more selective ERβ agonist. | |
| - | + | Looking at the gonadal steroid hormone estradiol,1, action is performed through estrogen subtypes, ERα and ERβ. The detrimental effects of ERβ in comparison to the proliferative effects ERα are found to inhibit breast and endometrial tissue compared to ERα and could potentially be responsible for the immunomodulatory and neuropharmacalogical behavior of estradiol 1,2. The interest in the therapeutic benefits of selective ERβ agonists to combatant various conditions including endometriosis and inflammatory bowel disease. | |
| - | + | This is an overall scene with the beta sheets in purple and the alpha helices in ball and stick figures <scene name='48/483890/Ben_homyak_overall_structure/1'>Overall Structure</scene> | |
| - | + | Here is another scene with a rainbow diagram description of the whole molecule | |
| + | <scene name='48/483890/2yly_overall_diagram/3'>Rainbow diagram</scene> | ||
| - | + | ==Overall Structure== | |
| + | The assembly composition of the 2yly protein is a homodimer. (Quaternary structure) | ||
| - | + | The DNA Binding domain is located in the C region, which is highly conserved. The ligand binding domain is located at the C terminus in the E and F regions. The ligand binding domain is often called the “three-layered anti-parallel α helical sandwich” because it contains 12 alpha helices along with one beta hairpin. Sites for dimerization and nuclear localization are located in the the D region, which is poorly conserved. Both ERα and ERβ have several splice variants, with ERα having over 20 and ERβ having 5. | |
| - | + | The 2yly protein's secondary structure consists of mostly alpha helices (148 residues) and only two beta strands (6 residues) on the outside of the receptor shown below with the alpha helices showing polar and non-polar parts of the chain. The beta sheets are shown in yellow in the second green scene. | |
| - | + | - <scene name='48/483890/2yly_alpha_helicies/1'>Alpha Helices</scene>, and <scene name='48/483890/2yly_beta_sheets/1'>Beta Sheets</scene> | |
| - | - | + | - Tertiary Structure |
| - | - | + | - Polar- Pink, Hydrophobic- Grey <scene name='48/483890/2yly_polar_hydrophobic/1'>Polar and Nonpolar Groups</scene> |
| - | - | + | - Surface groups (orange) vs. Buried groups (blue) <scene name='48/483890/2yly_surface_buried/1'>Check it out</scene> |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | <scene name='48/483890/ | + | |
==Binding Interactions== | ==Binding Interactions== | ||
| - | 1)Folding of protein | ||
| - | a | + | Among the series of p-hydroxybenzene sulfonamide ERβ receptor agonists discovered, protein 2yly has been identified for great selectivity over the related ERα receptor. Protein 2yly was originally designed to form an interaction with the His 475 through the tertiary hydroxyl group. However, the hydroxyl group serves as a conformational lock to form an internal hydrogen bond with the <scene name='48/483890/Soolim_binding/1'>sulphonamide oxygen </scene> about 2.3 Å apart.<sup>[1]</sup> |
| - | + | Internally packed against the phenyl group is the cyclopropyl group with large <scene name='48/483890/Soolim_hydrophobic/1'>hydrophobic interactions</scene> (shown in gray) between Ile 373 and both the benzyl and chiral methyl groups. The sulphonamide oxygens come in close contact with Met 336 and the benzyl group of the ligand comes near His 475 but there are no coulombic interactions formed. Depending on the functional group placed either next to the tertiary hydroxyl group or on the benzyl ring, further Van der Waals interactions can be seen within the lipophilic pocket. In other words, depending on the polarity of the group attached to the sulphonamide, interactions with His 475 will be varied. | |
| - | 2)Substrate binding | ||
| - | a) “phosphate-binding” pocket: describe three crucial basic residues (Show in different color on green screen) | ||
| - | |||
| - | b) GSK-3 substrates and binding specifics- S/TxxxS/T (S=Serine, T=threonine, X= any amino acid) | ||
| - | |||
| - | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217193/ | ||
| - | http://www.rcsb.org/pdb/explore/explore.do?pdbId=1Q3D | ||
| - | |||
| - | ==Additional Features== | ||
| - | |||
| - | The GSK-3β and staurosporine complex shows <scene name='48/483890/Additional_feature_v6/5'>unique hydrogen bonding (H-bond) interaction</scene> compared to the other protein-staurosporine complexes. | ||
| - | It is observed that there are direct H-bonds, water-mediated polar interactions and hydrophobic interactions in the GSK-3β and staurosporine complex. | ||
| - | There are only two direct H-bonds, and they are observed between | ||
| - | * The <span style="color:red">'''carbonyl oxygen'''</span> of Asp 133 and <span style="color:blue">'''N<sup>1</sup> (nitrogen)'''</span> of staurosporine. The length of this hydrogen bond is 2.93 Å. | ||
| - | * The backbone <span style="color:blue">'''nitrogen'''</span> of Val 135 and <span style="color:red">'''O<sup>5</sup> (oxygen)'''</span> of staurosporine. The length of this hydrogen bond is 2.76 Å. | ||
| - | |||
| - | Besides direct H-bond, the water-mediated polar interactions are observed between the <span style="color:red">'''carbonyl oxygen'''</span> of Gln 185 and <span style="color:blue">'''N<sup>4</sup> (nitrogen)'''</span> of the glycosidic ring. | ||
| - | The typical hydrogen bond (H-bond) is categorized to be between 2.2 and 4.0 Å (cite Jeffrey). | ||
| - | Since many pdb files lack hydrogen atoms, a significant H-bond can be considered when donor-acceptor distance are probably 3.5 Å (cite Jeffrey). | ||
| - | However, the length between between Gln 185 and Strauroporine is 4.47 Å which surpasses typical H-bond distance; therefore, it forms a water mediated polar interaction between these atoms instead of direct H-bond [cite J,A,Bertrand] | ||
| - | This is a unique interaction to the GSK-3β and staurosporine complex, since other protein kinase (e.g. CDK2, Chk1, LCK, PKA) -staurosporine complexes show direct H-bond interaction between two moieties. | ||
| - | |||
| - | There is a significant number of <scene name='48/483890/Additional_feature_v4/2'>hydrophobic interaction</scene> in the GSK-3β and staurosporine complex; to be more specific, this complex buries 891 Å<sup>2</sup> surface area [cite J,A,Bertrand]. The <span style="color:pink">'''hydrophobic residues'''</span> significantly interact with the fuzed carbazole moiety of saurosporine. | ||
| - | |||
| - | ==Quiz Question 1== | ||
| - | |||
| - | GSK-3 beta has various inhibiters; one example is AMP-PMP. These inhibitors bind to the N-terminus of the ligand on the GSK-3 beta complex, a result of the classical binding mechanism for a protein kinase. However, in the case of staurosporine (another inhibitor), it is unable to classically bind to the N-terminus of the ligand on the GSK-3 beta complex. This is because, in a GSK-3 beta complex with staurosporine, the ligand in question has an incompatible angle at the N-terminus, thus failing to undergo classical binding. | ||
| - | |||
| - | What type of bonding does GSK-3 beta exhibit with staurosporine, and which of its residues form this type of bond? A green screen of the complex as well as a lewis structure of the staurosporine molecule are found below, if needed. | ||
| - | |||
| - | http://upload.wikimedia.org/wikipedia/commons/3/34/Staurosporine1.png | ||
| - | |||
| - | <scene name='48/483890/Ligand_bonding_type/1'>View Complex</scene> | ||
| - | |||
| - | ==Quiz Question 2== | ||
| - | What are the locations of the active sites with respect to the two isoforms? | ||
| - | |||
| - | These green screens may help you. | ||
| - | |||
| - | <scene name='48/483890/Isophorms/2'>Color representation of the two isophorms complexed with the Staurosporine ligands</scene> | ||
| - | |||
| - | <scene name='48/483890/N_to_c_chain_rainbow/4'>Amino and Carboxy chain termini</scene> | ||
| - | |||
| - | {{Template:ColorKey_Amino2CarboxyRainbow}} | ||
| - | |||
| - | Answer: At the N and C terminal lobes. | ||
| - | |||
| - | J.A. Bertrand, S. Thieffine, A. Vulpetti, C. Cristiani, B. Valsasina, S. Knapp, H.M. Kalisz, M. Flocco, Structural Characterization of the GSK-3β Active Site Using Selective and Non-selective ATP-mimetic Inhibitors, Journal of Molecular Biology, Volume 333, Issue 2, 17 October 2003, Pages 393-407, ISSN 0022-2836, http://dx.doi.org/10.1016/j.jmb.2003.08.031. | ||
| - | (http://www.sciencedirect.com/science/article/pii/S0022283603010593) | ||
==See Also== | ==See Also== | ||
| - | *[ | + | *[[http://www.proteopedia.org/wiki/index.php/Estrogen_receptor Estrogen Receptor]] |
| - | + | *[[http://www.proteopedia.org/wiki/index.php/1yy4 1yy4]] | |
| - | *[http://proteopedia.org/wiki/index.php/ | + | *[[http://www.proteopedia.org/wiki/index.php/1u3s 1u3s]] |
| - | *[http://proteopedia.org/wiki/index.php/ | + | *[[http://www.proteopedia.org/wiki/index.php/1x78 1x78]] |
| - | *[http:// | + | *[[http://www.proteopedia.org/wiki/index.php/1qkm 1qkn]] |
| - | + | ||
| - | *[http://www.proteopedia.org/wiki/index.php/ | + | |
| - | + | ||
==Credits== | ==Credits== | ||
| - | Introduction - | + | Introduction - Benjamin Homyak |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | Overall Structure - Marissa Burgess | |
| - | + | Drug Binding Site - Soo Lim Park | |
==References== | ==References== | ||
<references/> | <references/> | ||
| - | (1) Bertrand, J. A., Thieffine, S., Vulpetti, A., et al. GSK-3 Beta complexed with Staurosporine 2003 | ||
| - | (2) Capra, M , Nuciforo, P Confalonieri, S Quarto, S Bianchi, M Nebuloni, M Boldorini, R Pallotti, F. Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers 2006 | ||
| - | |||
| - | (3) Hua F1, Zhou J, Liu J, Zhu C, Cui B, Lin H, Liu Y, Jin W, Yang H, Hu Z. Glycogen synthase kinase-3beta negatively regulates TGF-beta1 and Angiotensin II-mediated cellular activity through interaction with Smad3. 2010 | ||
Current revision
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
Estrogen receptor beta/p-hydroxybenzene sulfonamide complexes (2yly)[1]
by Benjamin Homyak, Soo Lim Park, Marissa Burgess
Student Projects for UMass Chemistry 423 Spring 2016
| |||||||||||
